Skip to content

Need of Atracurium (Neuromuscular blocking agents) based on Neuromuscular monitoring compared to clinical assessment parameters in patients undergoing Laparoscopic Cholecystectomy under General Anaesthesia

Assessment of requirement of Atracurium based on Neuromuscular monitoring compared to clinical assessment parameters in patients undergoing Laparoscopic Cholecystectomy under General Anaesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/07/026287
Enrollment
68
Registered
2020-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T481- Poisoning by, adverse effect of and underdosing of skeletal muscle relaxants [neuromuscular blocking agents]

Interventions

None listed

Sponsors

Lokmanya Tilak Municipal Medical College and General Hospital Mumbai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All consenting patients undergoing elective laparoscopic cholecystectomy â?? In age group of 18 to 65 years â?? American Society of Anesthesiologists (ASA)grade 1 or 2

Exclusion criteria

Exclusion criteria: â?? Patientâ??s refusal â?? Known allergy to the drugs used â?? Patients with anticipated difficult intubation - Malampatti class 3 or 4 â?? Body Mass Index >= 30 kg/m2 â?? Gastro-oesophageal reflux disease â?? H/o Cardiovascular, hepatic, renal, neuromuscular disorders â?? Pregnant patients

Design outcomes

Primary

MeasureTime frame
Compare the intraoperative doses and frequency of Atracurium with and without Neuromuscular monitoring in patients undergoing Laparoscopic Cholecystectomy.Timepoint: Compare the intraoperative doses and frequency of Atracurium with and without Neuromuscular monitoring in patients undergoing Laparoscopic Cholecystectomy. at baseline

Secondary

MeasureTime frame
To study the quality of relaxation at intubation. To study timing from last dose of muscle relaxant to extubation To study the quality of operative condition (based on Surgeonâ??s rating scale â?? from 1 to 3 Timepoint: To study the quality of relaxation at intubation. To study timing from last dose of muscle relaxant to extubation To study the quality of operative condition (based on Surgeonâ??s rating scale â?? from 1 to 3 for 2 hours

Countries

India

Contacts

Public ContactDr Sachin Devgude

lokmanya Tilak Municipal medical college and general hospital , sion Mumbai

drdeeptiagrawal@gmail.com9870135926

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026